Current market catalysts

Anthropic Pulls $450,000 Meta Sales Role as AI Rivalry With Facebook Parent Intensifies: Report

Meta reportedly drew Anthropic’s attention with a $380,000-plus sales role aimed at winning business from the AI giant’s strategic accounts.

8-K filing — Elevance Health, Inc. (ELV)

Filed: 2026-09-10 AccNo: 0001156039-26-000063 Size: 175 KB Item 7.01: Regulation FD Disclosure

Needham Reiterates Hold on Chewyto Hold

Needham analyst Bernie McTernan reiterates Chewy (NYSE:CHWY) from Hold to Hold.

Analyzing Amazon.com In Comparison To Competitors In Broadline Retail Industry

In today's rapidly evolving and fiercely competitive business landscape, it is crucial for investors and industry analysts to conduct comprehensive company evaluations. In this article, we will undertake an in-depth

Comparing Broadcom With Industry Competitors In Semiconductors & Semiconductor Equipment Industry

In the dynamic and fiercely competitive business environment, conducting a thorough analysis of companies is crucial for investors and industry enthusiasts. In this article, we will perform an extensive industry

Competitor Analysis: Evaluating Microsoft And Competitors In Software Industry

In today's rapidly changing and fiercely competitive business landscape, it is essential for investors and industry enthusiasts to thoroughly analyze companies. In this article, we will conduct a comprehensive

Evaluating Apple Against Peers In Technology Hardware, Storage & Peripherals Industry

In the dynamic and fiercely competitive business environment, conducting a thorough analysis of companies is crucial for investors and industry enthusiasts. In this article, we will perform an extensive industry

Market Analysis: NVIDIA And Competitors In Semiconductors & Semiconductor Equipment Industry

Amidst the fast-paced and highly competitive business environment of today, conducting comprehensive company analysis is essential for investors and industry enthusiasts. In this article, we will delve into an extensive

BTIG Upgrades Orchestra BioMed Hldgs to Buy, Announces $10 Price Target

BTIG analyst Marie Thibault upgrades Orchestra BioMed Hldgs (NASDAQ:OBIO) from Neutral to Buy and announces $10 price target.

TD Cowen Maintains Hold on Domino's Pizza, Raises Price Target to $320

TD Cowen analyst Andrew M. Charles maintains Domino's Pizza (NASDAQ:DPZ) with a Hold and raises the price target from $310 to $320.

BTIG Reiterates Buy on Navan, Maintains $30 Price Target

BTIG analyst Jake Fuller reiterates Navan (NASDAQ:NAVN) with a Buy and maintains $30 price target.

Method Security, Palantir Technologies Earlier Announced Cardinal Program To Provide Select Municipalities, Utilities And Critical Infrastructure Operators With Free Opt-In Continuous Autonomous Security Assessments

Top Wall Street Forecasters Revamp Adobe Expectations Ahead Of Q3 Earnings

Adobe reports Q3 earnings Sept. 10; analysts expect EPS of $6.09 and revenue of $6.70B. CEO transition and mixed analyst ratings weigh on shares.

What's Going On With Mastercard Stock Thursday?

Mastercard expands cross-border tech with Wallet Pay. Explore MA's price setup, analyst forecasts, and technical chart levels.

Stifel Reinstates Buy on Western Midstream, Announces $55 Price Target

Stifel analyst Robert Hodges reinstates Western Midstream (NYSE:WES) with a Buy and announces $55 price target.

BTIG Reiterates Buy on Jersey Mike's Subs, Maintains $28 Price Target

BTIG analyst Peter Saleh reiterates Jersey Mike's Subs (NYSE:JMKE) with a Buy and maintains $28 price target.

BTIG Reiterates Buy on BrainsWay, Maintains $20 Price Target

BTIG analyst Sam Eiber reiterates BrainsWay (NASDAQ:BWAY) with a Buy and maintains $20 price target.

Oracle Earnings Could Spark an 11% Stock Swing, Says Research Head: Here's Why Options Traders Are Betting on the Upside

Oracle is heading into earnings with options pricing an 11% stock move, while traders increasingly favor upside calls.

Stifel Reinstates Buy on Williams Companies, Announces $85 Price Target

Stifel analyst Robert Hodges reinstates Williams Companies (NYSE:WMB) with a Buy and announces $85 price target.

iPhone 17 Makes Apple History With Record First-Year Revenue

iPhone 17 revenue hits first-year revenue record. See Apple stock price targets, analyst ratings, and iPhone 18 foldable projections.

Seth Klarman's Hedge Fund Slashed This Stock by 54% — Even as It Scores Highly on Growth and Momentum

Seth Klarman's Baupost cut its Wesco stake by more than half, even though the stock ranks among the strongest in the fund's portfolio.

Keefe, Bruyette & Woods Upgrades Simmons First Ntl to Outperform, Maintains Price Target to $26

Keefe, Bruyette & Woods analyst Wood Lay upgrades Simmons First Ntl (NASDAQ:SFNC) from Market Perform to Outperform and maintains the price target from $26 to $26.

Sekisui House Q2 EPS $0.64 Down From $0.72 YoY, Sales $6.586B Down From $7.758B YoY

Sekisui House (OTC:SKHSY) reported quarterly earnings of $0.64 per share. This is a 11.11 percent decrease over earnings of $0.72 per share from the same period last year. The company reported $6.586 billion in sales

Coinbase CEO Makes Monster Bitcoin Call: $400,000 By 2030

Coinbase (COIN) gains as CEO Brian Armstrong and Needham analysts signal a crypto market bottom and coming U.S. regulatory clarity.

NVIDIA, Palantir Established AI Stack Combining Palantir Sovereign AI And Custom NVIDIA Nemotron Open Models For Complex Supply Chain Operations

Stock Market Today: Dow Futures Rise, S&P 500 Falls as Trump Promises $5,000 Dividend After Midterm Elections— AVAV, AEO, COO, ORCL in Focus (UPDATED)

U.S. stock futures were mixed on Thursday, as the Dow Jones and S&P 500 indices advanced, while the Nasdaq 100 index fell.

Forget Gold at $4,400? Economist Says A Bond Trade Could Be a Better Inflation Hedge

Morningstar's Preston Caldwell warns $4,400 gold is a trap for inflation fearmongers. Discover why he says investors should buy TIPS instead.

Goldman Sachs Initiates Coverage On Abivax with Buy Rating, Announces Price Target of $155

Goldman Sachs analyst Rajan Sharma initiates coverage on Abivax (NASDAQ:ABVX) with a Buy rating and announces Price Target of $155.

Evercore ISI Group Downgrades Chewy to In-Line, Announces $25 Price Target

Evercore ISI Group analyst Mark Mahaney downgrades Chewy (NYSE:CHWY) from Outperform to In-Line and announces $25 price target.

China Approves Novo Nordisk's Wegovy As First And Only GLP-1 RA Treatment For MASH

-Reuters